Sympathetic nerve aggravates autoimmune skin disease via NE–adrenergic receptor axis: Neuroimmune cross-talk insights from vitiligo
Science Advances · 2026
DOI: 10.1126/sciadv.aea7017 ↗At a glance
Journal article in Science Advances, 2026. Written by Luling Huang and 10 co-authors. Institution: Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No. 127 of West Changle Road, Xi'an, Shaanxi 710032, China. Major MEDLINE topics: Vitiligo, Sympathetic Nervous System, Receptors, Adrenergic, Norepinephrine. Cited 6 times so far (Crossref); 59 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China, Team Support Project for the Enhancement of Scientific Research and Innovation Capacity of the Shaanxi Provincial Health Commission.
Abstract (original language)
The dysregulation of cross-talk between the sympathetic nervous system (SNS) and the immune system is closely linked to the development of autoimmune diseases. This study used vitiligo as a model to elucidate the role of the SNS in autoimmune skin diseases. Evidence from clinical and animal studies confirmed abnormal activation of the SNS in vitiligo. Chemical sympathectomy improved the disease phenotype, reduced pathogenic cytokine levels, and inhibited the infiltration and effector functions of CD8 + T cells. Mechanistic investigations showed that norepinephrine (NE) released by the SNS interacts with adrenergic receptors to drive fibroblasts and keratinocytes to secrete chemokines CXCL9/10 and inflammatory mediators IL-6/15, establishing a pathological immune microenvironment conducive to the recruitment and activation of CD8 + T cells. Adrenergic receptor antagonists could reverse this abnormal immune microenvironment. This study elucidated the pathogenic mechanism of the SNS in vitiligo via the NE–adrenergic receptor–fibroblast/keratinocyte pathway, providing a theoretical foundation for neuroimmune therapy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No. 127 of West Changle Road, Xi'an, Shaanxi 710032, China.
ORCID profiles: Luling Huang, Pan Kang, Jiaxi Chen, Weiwei Sun, Hang Yin, Yuqi Yang, Sen Guo, Xiuli Yi, Jianru Chen, Shuli Li, Chunying Li
Funding
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Team Support Project for the Enhancement of Scientific Research and Innovation Capacity of the Shaanxi Provincial Health Commission
- Shaanxi Province Key Research and Development Program Major Projects
Cite
APA
Huang, L., Kang, P., Chen, J., Sun, W., Yin, H., Yang, Y., Guo, S., Yi, X., Chen, J., Li, S., & Li, C. (2026). Sympathetic nerve aggravates autoimmune skin disease via NE–adrenergic receptor axis: Neuroimmune cross-talk insights from vitiligo. Science Advances. https://doi.org/10.1126/sciadv.aea7017
Vancouver
Huang L, Kang P, Chen J, Sun W, Yin H, Yang Y, et al. Sympathetic nerve aggravates autoimmune skin disease via NE–adrenergic receptor axis: Neuroimmune cross-talk insights from vitiligo. Science Advances. 2026. doi:10.1126/sciadv.aea7017
BibTeX
@article{Huang2026,
author = {Huang, Luling and Kang, Pan and Chen, Jiaxi and Sun, Weiwei and Yin, Hang and Yang, Yuqi and Guo, Sen and Yi, Xiuli and Chen, Jianru and Li, Shuli and Li, Chunying},
title = {Sympathetic nerve aggravates autoimmune skin disease via NE–adrenergic receptor axis: Neuroimmune cross-talk insights from vitiligo},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aea7017}
}
EUVIMED